Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?
AuthorHurt, A; Komadina, N; Deng, Y-M; Kaye, M; Sullivan, S; Subbarao, K; Barr, I
PublisherEUR CENTRE DIS PREVENTION & CONTROL
Melbourne School of Population and Global Health
Microbiology and Immunology
Document TypeJournal Article
CitationsHurt, A., Komadina, N., Deng, Y. -M., Kaye, M., Sullivan, S., Subbarao, K. & Barr, I. (2017). Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?. EUROSURVEILLANCE, 22 (47), pp.2-9. https://doi.org/10.2807/1560-7917.ES.2017.22.47.17-00731.
Access StatusOpen Access
For over a decade virtually all A(H3N2) influenza viruses have been resistant to the adamantane class of antivirals. However, during the 2017 influenza season in Australia, 15/461 (3.3%) adamantane-sensitive A(H3N2) viruses encoding serine at residue 31 of the M2 protein were detected, more than the total number identified globally during the last 6 years. A return to wide circulation of adamantane-sensitive A(H3N2) viruses would revive the option of using these drugs for treatment and prophylaxis.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References